pyridinoline has been researched along with Paraproteinemias in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kapoor, S | 1 |
Chrz, M; Cieslar, P; Hulejová, H; Klener, P; Procházka, B; Spacek, P; Spicka, I; Válková, V | 1 |
Bayer, P; Diel, IJ; Horn, E; Keck, AV; Ludwig, H; Pecherstorfer, M; Seibel, MJ; Woitge, HW; Ziegler, R | 1 |
3 other study(ies) available for pyridinoline and Paraproteinemias
Article | Year |
---|---|
TGF-beta 1 and urinary excretion of pyridinium crosslinks: Two often overlooked risk factors for assessing risk of progression in patients with monoclonal gammopathy of undetermined significance.
Topics: Amino Acids; Bone Resorption; Diagnosis, Differential; Disease Progression; Humans; Multiple Myeloma; Paraproteinemias; Risk Factors; Transforming Growth Factor beta1; Ultrasonography | 2008 |
[Monitoring markers of bone turnover in multiple myeloma].
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Biomarkers; Bone Remodeling; Humans; Middle Aged; Multiple Myeloma; Osteocalcin; Paraproteinemias | 1999 |
Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma.
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone and Bones; Bone Neoplasms; Diagnosis, Differential; Female; Humans; Integrin-Binding Sialoprotein; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Osteocalcin; Osteoporosis; Paraproteinemias; Prognosis; Radioimmunoassay; Sialoglycoproteins; Survival Analysis | 2001 |